Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
Clinical trial NCT05470413 · UNKNOWN
Trial details
- NCT number
- NCT05470413
- Sponsor
- Reistone Biopharma Company Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-18
- Primary completion
- 2023-10-31
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.